PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 278 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by Analysts

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opp. Says Avere To Go Public Via Reverse Merger With NextCure

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US court blocks WuXi AppTec military tag, Korea biotech weighs impact - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RCS - Biotech Growth Trust - Kepler Trust Intelligence: New Research

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA Aims to Reduce Animal Testing to Modernize Drug Development

TechAcuteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Who is Tukaram Mundhe? The Maharashtra FDA Commissioner behind the raids shaking up Mumbai's iconic eateries

livemint.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sartorius Stedim Biotech : RBC remains its Buy rating

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune FDA action nets ₹41.36 lakh worth of prohibited food products; suspends 12 food establishments

Storyboard18Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cracks Down on Ayurvedic Manufacturers for Violations

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Launches Statewide Crackdown On Ayurvedic Drug Makers, Cancels 10 Licences Over Serious GMP &

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is Maharashtra FDA Cracking Down on Ayurvedic Drug Makers?

openthemagazine.comOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Update on Alert: Convenience Kit Issue from Medline

Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.

FDA MedWatchOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Convenience Kit Correction: Medline Issues Correction for Convenience Kits Containing ICU Medical Pain Management Components

Medline is correcting affected convenience kits by removing included ICU Medical pain management com...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India News

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics completes phase 3 enrollment for OPGx-LCA5 gene therapy

Glance by Eyes On EyecareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Permanently Cancels Licences of 10 Ayurvedic Drug Manufacturers Over Serious GMP and Safety Lapses; Show-Cause Notices Issued to 135 Others

drugscontrol.orgOriginal source
🇺🇸Industry4gclinical.comTier 1 · Company source

Adaptive Trials Made Movement Part of the Model - Science in Motion

4G ClinicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva (TEVA) Is Up 6.0% After Moody’s Upgrade To Investment Grade And Higher 2026 Guidance

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends licence of Sillod ST canteen over safety violations

Mid-DayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends licences of 12 food establishments in Pune, Sangli; seizes ₹41.36 lakh stock | Hindustan Times

Hindustan TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract

The Globe and MailOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Belenos Biosciences Announces Positive Topline Results from a Phase 2 Clinical Trial of BEL512 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharma’s epaminurad 6 mg outperforms febuxostat 40 mg in phase 3 gout trial

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract

Rutland HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract

newswire.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enveda CEO Viswa Colluru on AI and biotech: 'we're at a unique moment in time'

qz.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical's Gout Drug Succeeds in Low-Dose Phase 3 Trial; Shares Surge 17% on Strong Q2 Earnings

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teknova: Build-Tek AI Configures Complex Custom Reagents In Minutes As Biotech Manufacturing Platform Expands

Pulse 2.0Original source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical Jumps 15% on Gout Drug Phase 3 Success

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Imunon Q2 2026: $0.54/Share Loss Beats Estimates — Deep Dive

AlphaStreetOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Invited Presentation at VASSCAA-13 & KVS 2026

Ulvac (Pharma)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical jumps on phase 3 success for gout drug, targets Korea NDA - CHOSUNBIZ

ChosunbizOriginal source
🌍Industrypetros.comTier 1 · Company source

Catering Menu — Petros® Love at First Bite

Petros PharmaceuticalsOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: MC38 B2m KO Cell Line

The National Cancer Institute (NCI) seeks licensees for a CRISPR/Cas9-engineered MC38 B2m knockout m...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Prospective Grant of an Exclusive Patent License: Development and Commercialization of BL-760 Dye for Intraoperative Fluorescence Imaging

The National Cancer Institute, an institute of the National Institutes of Health, Department of Heal...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Monoclonal Antibody (RO4) That Reacts With the Juxta-Membrane Region of Mesothelin

The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a n...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Human Antibodies Targeting Beneficial Viral Peptide in Liver Cancer

The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to deve...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: DNA Methylation-Based Cancer Diagnostics for Accurate Tumor Classification

This technology encompasses a DNA methylation-based diagnostic platform designed to improve the accu...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions

Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic an...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Quantitative Particle Identification (QPID) Digital Autoradiography System

The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a Q...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

NIH Owned Invention Available for License: Drug-Regulatable, Inducible Expression of Membrane-Bound Interleukin 12 (DRIM-IL-12) for Use in Adoptive Cell Therapy

Scientists at the National Cancer Institute (NCI) have developed a novel tightly regulated drug-resp...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Guide To Minimize Biological Hazards in Ready-to-Eat Fresh-Cut Produce; Guidance for Industry; Availability

The Food and Drug Administration (FDA or we) is announcing the availability of a final guidance for...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Adoption and Foster Care Analysis and Reporting System

This document withdraws a proposed rule that was published in the Federal Register on January 11, 20...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I

The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (oth...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Solicitation of Nominations for Membership on the National Vaccine Advisory Committee

The Office of the Assistant Secretary for Health (OASH) is seeking nominations for membership on the...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Newborn Screening Stakeholder Workgroup

HRSA provides funding to support a national center for newborn screening systems known as the Nation...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Announcement of the Intent To Award Sole-Source Awards to the Federated States of Micronesia and the Republic of the Marshall Islands

The ACF, OHS announces the intent to award two sole-source grants in the total amount of up to $7,20...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine

Official structured record identifier: a33b6ed6-2c75-4bab-98e5-a7f8bea21926.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Mineral oil

Official structured record identifier: 92f2147d-b52d-4282-b217-28f6095dca0e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CVS PHARMACY Assorted Fruit Antacid

Official structured record identifier: 8ab371eb-9839-47f0-b576-d917f69ed16d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CVS PHARMACY Assorted Berry Antacid

Official structured record identifier: 7f0a4d88-4e3c-448e-90b1-ae03966b7806.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Hydrogen Peroxide 3 Percent

Official structured record identifier: 7e5f175d-f0d6-4665-ac14-1873d6b99c80.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CVS Ultra Strength

Official structured record identifier: 6108271a-4336-4f90-9765-9c3aea109488.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CVS PHARMACY,INC. Assorted Fruit

Official structured record identifier: 60294e90-4b9c-4419-876c-3da037d76cfd.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: meloxicam

Official structured record identifier: 58d34e5d-4efb-3d76-e063-6394a90aa0f6.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Pantoprazole Sodium

Official structured record identifier: 58d32be2-166e-1a64-e063-6394a90a26ea.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Amlodipine Besylate

Official structured record identifier: 58d2fbed-3904-3e31-e063-6294a90af21d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Buprenorphine and Naloxone Sublingual Film

Official structured record identifier: 58d2c995-c0cf-a007-e063-6394a90a3f77.

openFDA Drug LabelsOriginal source